Share your thoughts and join the conversation in the comments.

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

"Big Pharma" stocks took a tumble this morning following the news that President-elect Donald Trump has appointed Robert F.

Shares of drugmakers AstraZeneca dropped 2.4% and GSK dipped 3.2%, tracking losses in U.S. and European vaccine makers after ...

Pharmaceutical stocks declined as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department ...

The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.

Global stocks fell after Jerome Powell signaled the Federal Reserve was in no rush to cut interest rates, and unease built ...

LONDON, UK I 14, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results from a planned interim analysis of the DREAMM-7 ...

(Reuters) -Shares in global vaccine makers fell sharply on Friday after U.S. President-elect Donald Trump picked Robert F.

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer.

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK plc (GSK, GSK.L), on Thursday, announced positive headline results from a planned interim analysis of the DREAMM-7 head-to-head ...